Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.

Muscle-specific tyrosine kinase (MuSK) autoantibodies are the hallmark of a form of myasthenia gravis (MG) that can challenge the neurologist and the experimentalist. The clinical disease can be difficult to treat effectively. MuSK autoantibodies affect the neuromuscular junction in several ways. Wh...

Полное описание

Библиографические подробности
Главные авторы:	Phillips, W, Christadoss, P, Losen, M, Punga, A, Shigemoto, K, Verschuuren, J, Vincent, A
Формат:	Journal article
Язык:	English
Опубликовано:	Academic Press Inc. 2015

Схожие документы

Myasthenia gravis with MuSK antibodies
по: Farrugia, M, и др.
Опубликовано: (2005)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
по: Koneczny, I, и др.
Опубликовано: (2014)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
по: Koneczny, I, и др.
Опубликовано: (2014)

Potential mechanisms in MuSK-myasthenia gravis
по: Koneczny, I
Опубликовано: (2014)

MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
по: Shalini Bhaskar, и др.
Опубликовано: (2022-01-01)

Infantile Onset Myasthenia Gravis with MuSK Antibodies
по: J Gordon Millichap
Опубликовано: (2006-08-01)

The prevalence of MuSK antibody positive myasthenia gravis worldwide
по: Vincent, A, и др.
Опубликовано: (2006)

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
по: McConville, J, и др.
Опубликовано: (2004)

MuSK antibody-positive, seronegative myasthenia gravis in Korea.
по: Lee, J, и др.
Опубликовано: (2006)

MuSK Antibody Positive Myasthenia Gravis Mimicking as Myositis
по: Nilesh Wagh, и др.
Опубликовано: (2024-09-01)

MuSK-Associated Myasthenia Gravis: Clinical Features and Management
по: Carmelo Rodolico, и др.
Опубликовано: (2020-07-01)

Patient-specific therapeutic benefit of MuSK agonist antibody ARGX-119 in MuSK myasthenia gravis passive transfer models
по: Jamie L. Lim, и др.
Опубликовано: (2025-02-01)

MuSK-antibody-positive myasthenia gravis in a South Asian population.
по: Chang, T, и др.
Опубликовано: (2009)

Anti-MuSK antibodies in a case of ocular myasthenia gravis.
по: Bennett, D, и др.
Опубликовано: (2006)

Anti-MuSK antibody positive myasthenia gravis with childhood onset
по: Diana Epure, и др.
Опубликовано: (2016-06-01)

Progress in rituximab for anti⁃MuSK antibody-related myasthenia gravis
по: Ting LI, и др.
Опубликовано: (2020-01-01)

Clinical Characteristics of MuSK Antibody-positive Myasthenia Gravis in Taiwan
по: Yung-Chuan Huang, и др.
Опубликовано: (2008-07-01)

Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation
по: Newsom-Davis, J, и др.
Опубликовано: (2001)

Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
по: Niks, E, и др.
Опубликовано: (2006)

Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese.
по: Yeh, J, и др.
Опубликовано: (2004)

Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
по: Cao, M
Опубликовано: (2021)

Efgartigimod treatment in patients with anti-MuSK-positive myasthenia gravis in exacerbation
по: Fangyi Shi, и др.
Опубликовано: (2024-11-01)

Coexistence of anti-MuSK antibody-positive myasthenia gravis and rheumatoid arthritis
по: Amber Eker, и др.
Опубликовано: (2020-08-01)

Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China
по: Zunwei Zhang, и др.
Опубликовано: (2020-10-01)

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
по: Shiraishi, H, и др.
Опубликовано: (2005)

Myasthenia Crisis as First Presentation of MuSk Positive Myasthenia Gravis: A Case Report
по: Dipesh Chhetri, и др.
Опубликовано: (2025-02-01)

Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis
по: Lee, J, и др.
Опубликовано: (2016)

Anti-MuSK-Positive Myasthenia Gravis in a Patient with Parkinsonism and Cognitive Impairment
по: S. Lanfranconi, и др.
Опубликовано: (2011-01-01)

MuSK Myasthenia Gravis—Potential Pathomechanisms and Treatment Directed against Specific Targets
по: Edyta Dziadkowiak, и др.
Опубликовано: (2024-03-01)

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience
по: Christiane Schneider-Gold, и др.
Опубликовано: (2017-10-01)

Quantitative EMG studies to assess facial muscle atrophy in MuSK antibody positive myasthenia gravis
по: Farrugia, M, и др.
Опубликовано: (2007)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
по: Aigli G. Vakrakou, и др.
Опубликовано: (2023-07-01)

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
по: Vuslat Yilmaz, и др.
Опубликовано: (2015-01-01)

Anti-MuSK antibody positive myasthenia gravis with Graves disease: one case report
по: Shan CAO, и др.
Опубликовано: (2019-02-01)

MuSK Myasthenia Gravis in an HIV-infected Chinese old man successfully treated with pyridostigmine
по: Yirui Xie, и др.
Опубликовано: (2020-09-01)

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
по: Deymeer, F, и др.
Опубликовано: (2007)

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
по: Farrugia, M, и др.
Опубликовано: (2006)

Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1.
по: Niks, E, и др.
Опубликовано: (2008)

A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression
по: Koneczny, I, и др.
Опубликовано: (2024)

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
по: Hoch, W, и др.
Опубликовано: (2001)